Browsing by Author "P.C. Okechukwu Ugwu"

Now showing 1 - 2 of 2
  • Thumbnail Image
    Item
    A Review of Incidence and Clinical Outcomes of Neonate with False Tooth Extraction
    (Journal of Scientific Research, 2023) Emmanuel Ifeanyi Obeagu; Neema Bizimana Gloria; Getrude Uzoma Obeagu; Getrude Uzoma Obeagu; P.C. Okechukwu Ugwu
    False tooth extraction is a cultural practice which have been reported in countries in Sub-Saharan as a management of fever, difficult in breastfeeding and diarrhoea in infants, and this has been thought to increase infant mortality. When false tooth is diagnosed it is advices before performing tooth extraction in neonate to wait for the commensal flora of the intestine to become established and to produce vitamin K, which is essential for the production of prothrombin in the liver. Thus, it is safer to wait until a child is 10 days old before extracting the tooth.
  • Thumbnail Image
    Item
    An Update of Aneamia in Adults with Heart Failure
    (International Network Organization for Scientific Research, 2023) Emmanuel Ifeanyi Obeagu; Maria Mudei Ali; Esther U. Alum; Getrude Uzoma Obeagu; P.C. Okechukwu Ugwu; Umi Omar Bunu
    Anaemia in adults with heart failure occurs when there is a deficiency of erythrocytes or haemoglobin in the blood, which further lowers the already limited oxygen supply to the body's tissues in heart failure. Anaemia is typically caused by poor nutrition, chronic kidney disease, inflammation, and certain medications used to treat heart failure. Symptoms of anaemia in adults with heart failure can include fatigue, weakness, and shortness of breath, increased heart rate, and chest pain. Treatment involves addressing underlying causes, improving nutrition, and in some cases, iron supplementation to increase red blood cell production. Close monitoring and coordination with healthcare providers is important to manage both heart failure and anaemia in adults, erythropoietin-stimulating agents has been considered alone or in combination with iron. Available and emerging new agents in the treatment of anaemia of heart failure will need to be tested in randomized, controlled studies.